AKT1 and neoplasm: Additional mutations in the PI3K/AKT/mTOR pathway were also found in these neoplasms, such as those affecting TSC1/2 and PTEN tumor suppressor genes, and pronounced losses of these genes were correlated with liver metastases, shorter time to progression, and shorter disease-free and overall survival5,6,8.